Literature DB >> 2023183

The L1 protein as a new indicator of inflammatory activity in patients with juvenile rheumatoid arthritis.

H B Berntzen1, M K Fagerhol, M Ostensen, P Mowinckel, H M Høyeraal.   

Abstract

L1 is a major granulocyte and monocyte protein with Mr 36.5 kDa. It is released during leukocyte activation and detected in plasma by use of an enzyme immunoassay. In our study, L1, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), orosomucoid and haptoglobin were analyzed in 127 patients with juvenile rheumatoid arthritis (79 pauci, 33 poly and 15 systemic). L1, ESR and the acute phase proteins were all found to have positive correlations with the clinical joint assessments, with L1 having the strongest correlations. High correlation coefficients were found between L1 and orosomucoid (r = 0.83), ESR (r = 0.72), haptoglobin (r = 0.71) and CRP (r = 0.65), with p less than 0.001 for all the correlations.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2023183

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  8 in total

1.  Plasma calprotectin levels in patients suffering from acute pancreatitis.

Authors:  Antonio Carroccio; Pasquale Rocco; Pier Giorgio Rabitti; Lidia Di Prima; Giovanni Battista Forte; Angelo B Cefalù; Franco Pisello; Girolamo Geraci; Generoso Uomo
Journal:  Dig Dis Sci       Date:  2006-10       Impact factor: 3.199

2.  Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis.

Authors:  Hilde Berner Hammer; Sigrid Odegard; Magne K Fagerhol; Robert Landewé; Désirée van der Heijde; Till Uhlig; Petter Mowinckel; Tore K Kvien
Journal:  Ann Rheum Dis       Date:  2007-01-18       Impact factor: 19.103

3.  Myeloid-related protein 8/14 in plasma and serum in patients with new-onset juvenile idiopathic arthritis in real-world setting in a single center.

Authors:  Paula L Keskitalo; Salla M Kangas; Sirja Sard; Tytti Pokka; Virpi Glumoff; Petri Kulmala; Paula Vähäsalo
Journal:  Pediatr Rheumatol Online J       Date:  2022-06-16       Impact factor: 3.413

4.  Chemotaxins C5a and fMLP induce release of calprotectin (leucocyte L1 protein) from polymorphonuclear cells in vitro.

Authors:  G Hetland; G J Talgö; M K Fagerhol
Journal:  Mol Pathol       Date:  1998-06

5.  The soluble biomarker calprotectin (an S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab.

Authors:  Hilde Berner Hammer; Magne K Fagerhol; Tale Norbye Wien; Tore K Kvien
Journal:  Arthritis Res Ther       Date:  2011-10-26       Impact factor: 5.156

6.  The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis.

Authors:  Katsue Sunahori; Masahiro Yamamura; Jiro Yamana; Kouji Takasugi; Masanori Kawashima; Hiroshi Yamamoto; Walter J Chazin; Yuichi Nakatani; Satoru Yui; Hirofumi Makino
Journal:  Arthritis Res Ther       Date:  2006-04-13       Impact factor: 5.156

7.  Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis.

Authors:  Jana Hurnakova; Jakub Zavada; Petra Hanova; Hana Hulejova; Martin Klein; Herman Mann; Olga Sleglova; Marta Olejarova; Sarka Forejtova; Olga Ruzickova; Martin Komarc; Jiri Vencovsky; Karel Pavelka; Ladislav Senolt
Journal:  Arthritis Res Ther       Date:  2015-09-15       Impact factor: 5.156

8.  Serum calprotectin--a promising diagnostic marker for adult-onset Still's disease.

Authors:  Qian Guo; Xicao Zha; Chun Li; Yuan Jia; Lei Zhu; Jianping Guo; Yin Su
Journal:  Clin Rheumatol       Date:  2015-11-07       Impact factor: 2.980

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.